Anatomic and functional results of vitrectomy and long-term intraocular tamponade for stage 2 macular holes

Retina

Volumn 23, Issue 1, 2003, Pages 57-63

  Dori, Dalia ^a,b   Thoelen, Adelheid M ^a   Akalp, Fatma ^a   Bernasconi, Paolo P ^a   Messmer, Elmar P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Macular hole; Perfluropropane gas; Vitrectomy

Indexed keywords

INDOCYANINE GREEN; OCTAFLUOROPROPANE; SILICONE OIL;

ADULT; AGED; ARTICLE; BODY POSITION; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; POSTOPERATIVE PERIOD; RETINA INJURY; RETINA MACULA HOLE; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; TIME; VISUAL ACUITY; VITRECTOMY;

ADULT; AGED; COLORING AGENTS; FEMALE; FLUOROCARBONS; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PRONE POSITION; RETINA; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; SILICONE OILS; VISUAL ACUITY; VITRECTOMY;

EID: 0037299881     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200302000-00009     Document Type: Article

References (29)

1. Kim JW, Freeman WR, Azen SP, et al. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Am J Ophthalmol 1996;121:605-614.
2. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991;109:654-659.
3. Monin C, Barale PO, Harrabi S, Haut J. Traitement chirurgical par vitrectomie et sérum autologue de trente-six trous maculaires idiopathiques. J Fr Ophtalmol 1996;19:341-348.
4. Kusaka S, Sakagami K, Kutsuna M, Ohashi Y. Treatment of full-thickness macular holes with autologous serum. Jpn J Ophthalmol 1997;41:332-338.
5. Ryan EH Jr, Gilbert HD. Results of surgical treatment of recent-onset full-thickness idiopathic macular holes. Arch Ophthalmol 1994;112:1545-1553.
6. Faude F, Edel E, Dannhauer M, et al. Autologe Thrombozytenapplikation bei der Behandlung des idiopathischen Makulaforamens. Ophthalmologe 1997;94:877-881.
7. Thompson JT, Smiddy WE, Glaser BM, et al. Intraocular tamponade duration and success of macular hole surgery. Retina 1996;16:373-382.
8. 2 for the treatment of full-thickness macular holes. Ophthalmology 1992;99:1162-1173.
9. Lansing MB, Glaser BM, Liss H, et al. The effect of pars plana vitrectomy and transforming growth factor-beta-2 without epiretinal membrane peeling on full-thickness macular holes. Ophthalmology 1993;100:868-872.
10. Vine AK, Johnson MW. Thrombin in the management of full thickness macular holes. Retina 1996;16:474-478.
11. Thompson JT, Smiddy WE, Williams GA, et al. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 1998;105:700-706.
12. Paques M, Chastang C, Mathis A, et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole. Results of a multicenter, double-masked, randomized trial. Ophthalmology 1999;106:932-938.
13. Banker AS, Freeman WR, Azen SP, et al. A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Arch Ophthalmol 1999;117:1499-502.
14. Ruby AJ, Williams DF, Grand MG, et al. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 1994;112:359-364.
15. Mester V, Kuhn F. Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol 2000;129:769-777.
16. Ellis JD, Malik TY, Taubert MAK, et al. Surgery for full-thickness macular holes with short-duration prone posturing: results of a pilot study. Eye 2000;14:307-312.
17. Olsen TW, Sternberg P Jr, Capone A Jr, et al. Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane. Retina 1998;18: 322-329.
18. Margherio RR, Margherio AR, Williams GA, et al. Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes. Arch Ophthalmol 2000; 118:495-498.
19. Thompson JT, Glaser BM, Sjaarda RN, et al. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 1994;101:1195-1200.
20. Byhr E, Lindblom B. Macular hole surgery without routine membrane excision or use of adjuvants. Acta Ophthalmol Scand 2000;78:451-455.
21. Brooks HL Jr. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 2000;107:1939-1949.
22. Mulhern MG, Cullinane A, Cleary PE. Visual and anatomical success with short-term macular tamponade and autologous platelet concentrate. Graefes Arch Clin Exp Ophthalmol 2000;238:577-583.
23. Kadonosono K, Itoh N, Uchio E, et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-1118.
24. Gass JDM. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995;119:752-759.
25. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. St. Louis: Mosby, 1997:938-951.
26. Haritoglou C, Gass CA, Schaumberger M, et al. Macular changes after peeling of the internal limiting membrane in macular hole surgery. Am J Ophthalmol 2001;132:363-368.
27. Gandorfer A, Haritoglou C, Gass C, et al. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 2001;132:431-433.
28. Park SS, Marcus DM, Duker JS, et al. Posterior segment complications after vitrectomy for macular hole. Ophthalmology 1995;102:775-781.
29. Banker AS, Freeman WR, Kim JW, et al. Vision-threatening complications of surgery for full-thickness macular holes. Ophthalmology 1997;104:1442-1453.